EMEA Active Pharmaceutical Ingredients Market Analysis & Forecast 2024-2030

EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredients Market Report by Product Type (Synthetic APIs, Biotech APIs ) by Application /End User (CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology ) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)

Report Code: PSMR- 20068          Category: Pharmaceutical          Region :  Global         Report Format :                  

 Request Free Sample


    ×

     Table of Contents

    Global EMEA Active Pharmaceutical Ingredients Market is expected to reach USD 173627.66 million by 2030 with CAGR of 9.4% between 2024 and 2030

    The actual sales of active pharmaceutical ingredients in EMEA market are about 9850 K MT. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Our report on EMEA covers Europe, Middle East and Africa. Europe segment covers Germany, France, UK, Russia, Italy and Benelux while Middle East includes Saudi Arabia, Israel, UAE and Iran. Africa includes South Africa, Nigeria, Egypt and Algeria.  


    EMEA Active Pharmaceutical Ingredients Market

    Well established healthcare services, adequate manufacturing units, a higher spending power, technological advancements in the process of API manufacture, and rising preference for targeted therapy approach in cancer treatment are driving the EMEA active pharmaceutical ingredients market. Stringent regulatory framework across several regions with different regulatory requirements in each country has made this an extremely complex market in the recent times. With European Union, several other countries are adopting fierce regulatory requirements and enforcing active pharmaceutical ingredients inspection system similar to the level of FDA which is a step towards standardized regulatory framework globally. This is restricting the growth of this market in many countries.  


    Profshare Market Research launches an in-detailed study of segments, market drivers, constraints, regional analysis, trends and forecast on Active Pharmaceutical Ingredients Market. The market is expected to show constant growth between 2024 to 2030. The study covers a detailed analysis, growth and forecast of Active Pharmaceutical Ingredients Market. The report includes market analysis on regional level. The study covers historical data analysis from 2018 to 2023 and market forecast for 2024 to 2030 based on revenue generated.  


    In competition analysis report covers key player’s basic information, product category, Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%). The competitive landscape in the report offers detailed profiles of the key players in Active Pharmaceutical Ingredients Market. The report also covers financial overview, market strategies, new product analysis and marketing trends. Precise Competitive analysis helps businesses to build new product strategies. The study includes market value in terms of revenue in billion USD for years and compound annual growth rate (CAGR) in % from 2024 to 2030.  


    Research report includes major player analysis with shares of each player inside market, growth rate and market attractiveness in different end-users/regions. Our study on Active Pharmaceutical Ingredients Market helps users to make precise decision to expand their market presence and increase their market share. The competitive landscape in the report offers detailed profiles of the key players in Active Pharmaceutical Ingredients Market also covers financial overview, market strategies, new product analysis and marketing trends. Precise Competitive analysis helps businesses to build new product strategies.  


    EMEA Active Pharmaceutical Ingredients Market: Product Type

    • Synthetic APIs
    • Biotech APIs

    EMEA Active Pharmaceutical Ingredients Market: Application

    • CNS
    • Cardiovascular
    • Genitourinary/Hormonal Drugs
    • Respiratory
    • Rheumatology
    • Diabetes
    • Oncology

    EMEA Active Pharmaceutical Ingredients Market : Companies Covered

    Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in EMEA Active Pharmaceutical Ingredients Market:

    • Teva
    • Mylan
    • DSM
    • Aurobindo Pharma
    • Aspen
    • Novartis
    • BASF
    • Pfizer
    • Huahai Pharmaceutical
    • Hisun Pharmaceutical
    • Sun Pharmaceutical Industries
    • Zhejiang Medicine
    • Dr. Reddy’s Laboratories
    • Zhejiang NHU
    • Bayer
    • NCPC
    • AbbVie
    • Shandong Xinhua Pharmaceutical
    • Northeast Pharm

    Global EMEA Active Pharmaceutical Ingredients Market Report delivers a comprehensive analysis of the following parameters:

    • Market Forecast for 2024-2030
    • Market growth drivers
    • Challenges and Opportunities
    • Emerging and Current market trends
    • Market player Capacity, Production, Revenue (Value)
    • Supply (Production), Consumption, Export, Import analysis
    • End user/application Analysis

    Report Coverage

    Parameters Details

    Base Year

    2023

    Historical Data

    2018-2023

    Forecast Data

    2024-2030

    Base Year Value (2023)

    USD 92575.84 million

    Forecast Value (2030)

    USD 173627.66 million

    CAGR (2022 to 2028)

    9.4 %

    Regional Scope

    North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW


    Frequently Asked Questions (FAQ)


    EMEA Active Pharmaceutical Ingredients Market was valued at around USD 92575.84 million in 2023 & estimated to reach USD 173627.66 million by 2030.




    EMEA Active Pharmaceutical Ingredients Market is likely to grow at compounded annual growth rate (CAGR) of 9.4% between 2024 to 2030.












    Yes, the report includes COVID 19 impact on the market.



    Purchase Options

      Online Access $2450

      PDF Access $3550

      PDF + Dashboard $4050
        Access

    Inquire Before Buying

    Please fill below details:

      ×
      Free Customization

      We are committed to offering 100 % free customization while purchasing.



        Access the FREE Sample

        Receive a detailed insight into the EMEA Active Pharmaceutical Ingredients Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.

         Request Free Sample


          ×